A Study of HBS-201 (Pitolisant Delayed-release)
Public ClinicalTrials.gov record NCT07051252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Open-Label Study of HBS-201 (Pitolisant Delayed-release) in Adult Participants With Narcolepsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the tolerability of HBS-201 when starting at a therapeutic dose in adult participants with narcolepsy.
Study identification
- NCT ID
- NCT07051252
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 46 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2025 (Actual)
- Primary completion
- Oct 13, 2025 (Actual)
- Completion
- Oct 13, 2025 (Actual)
- Last update posted
- Dec 12, 2025
2025
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmony Site 9 | San Ramon | California | 94583 | — |
| Harmony Site 14 | Brandon | Florida | 33511 | — |
| Harmony Site 4 | Miami | Florida | 33176 | — |
| Harmony Site 8 | Atlanta | Georgia | 30328 | — |
| Harmony Site 13 | Newton | Massachusetts | 02459 | — |
| Harmony Site 11 | Troy | Michigan | 48085 | — |
| Harmony Site 10 | Denver | North Carolina | 28037 | — |
| Harmony Site 2 | Huntersville | North Carolina | 28078 | — |
| Harmony Site 6 | Canton | Ohio | 44718 | — |
| Harmony Site 1 | Cincinnati | Ohio | 45245 | — |
| Harmony Site 15 | Wyomissing | Pennsylvania | 19610 | — |
| Harmony Site 5 | Columbia | South Carolina | 29201 | — |
| Harmony Site 12 | North Charleston | South Carolina | 29406 | — |
| Harmony Site 3 | Austin | Texas | 78731 | — |
| Harmony Site 7 | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07051252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2025 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07051252 live on ClinicalTrials.gov.